Primary Myelofibrosis Recruiting Phase Trials for Sirolimus (DB00877)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02917096Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With MyelofibrosisSupportive Care